Emerald by Euclid

The prevalence of myopia has rapidly increased over the last 30 years and is now a major health concern.

There are approximately 1.5 billion people worldwide with myopia – more than 25% of the global population. By 2020, it is said that an additional 1 billion people may develop this vision condition, including at the age of 6 when children can begin the development process.

With myopia growing at an alarming rate, Euclid has been the leader in myopia management for over twenty years. Euclid manufactures Ortho-K product, Emerald – a FDA approved, safe, and reversible and correct vision overnight by gently re-shaping the cornea. Patients remove Emerald in the morning and go throughout the day without any other vision correction.

It is Euclid's mission to be the world's leading prescribed product for managing myopia by providing your patients with crisp, clear vision without the typical choices of glasses, daytime contact lenses, or LASIK surgery. Grow your practice while exciting your patients with a proven vision correction option that can enhance their life!